Ursodiol Tablet, Film Coated
Product Images NDC 55154-2633

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ursodiol (NDC 55154-2633). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

250mg Bag Label (61dcaec8 3acb 4ef0 Afde 65a66e99afa7 00)

250mg Bag Label (61dcaec8 3acb 4ef0 Afde 65a66e99afa7 00)
This is a description of Ursodiol tablets, USP 250 mg. The usual adult dosage is 13 to 15 mg per kg per day in two to four divided doses with food, as per the product insert on www.majorpharmaceuticals.com. The tablets must be stored at 20° to 25° C and dispensed in a tightly sealed, light-resistant container. The packaging is not child-resistant and is meant for institutional use only. The drug is distributed by Par Pharmaceutical and made in Italy. It is a product of Par Formulations Private Limited and distributed in the USA by Major Pharmaceuticals through Cardinal Health.*
FDA Label Image

Ursodiol-structure.jpg (Ursodiol Tablet 1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.